论文部分内容阅读
目的:探讨中医辨证分型联合放疗治疗晚期鼻咽癌的疗效。方法:收治晚期鼻咽癌98例患者,分为A、B两组。A组60例为治疗组中医辨证分型+放疗,B组为38例为对照组(单独放疗),对两组的疗效予以观察对比。结果:总有效率A组95.5%,B组90%。3年生存率A组83.52%,B组70%。结论:中医辨证分型联合放疗治疗晚期鼻咽癌,不但能增强机体免疫力,减轻患者的放疗反应,能够起到相得益彰的效果。
Objective: To investigate the curative effect of TCM syndrome differentiation combined with radiotherapy for advanced nasopharyngeal carcinoma. Methods: 98 patients with advanced nasopharyngeal carcinoma were divided into A and B groups. A group of 60 cases for the treatment group TCM differentiation type + radiotherapy, B group 38 cases for the control group (radiotherapy alone), the efficacy of the two groups were observed and compared. Results: The total effective rate was 95.5% in group A and 90% in group B. The 3-year survival rate was 83.52% in group A and 70% in group B. Conclusion: TCM syndrome differentiation combined with radiotherapy in the treatment of advanced nasopharyngeal carcinoma can not only enhance the immunity of the body and relieve the patients’ radiotherapy response, but also play a complement effect.